These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 13423436)

  • 1. [Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man].
    KLOTZBUCHER E
    Z Gesamte Inn Med; 1956 Dec; 11(23):1075-81. PubMed ID: 13423436
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new antidiabetic N-sulfanilyl-N'-butyl urea (BZ 55); preliminary results].
    CHAIA J
    Rev Med Moyen Orient; 1957; 14(1):47-50. PubMed ID: 13454198
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood crasis, Mommsen granulations and leukocytic glycogen in diabetics treated with N'-sulfanilyl-N2-n-butyl urea].
    PELLEGRINI R; RUMPIANESI G
    Endocrinol Sci Cost; 1956; 23(4):272-8. PubMed ID: 13404963
    [No Abstract]   [Full Text] [Related]  

  • 4. [Electrophoretic serous patterns (proteins, lipoproteins and glycoproteins) of diabetics during treatment with N-sulfanilyl-N'-butyl urea and N-tolyl-sulfonyl-N'-butyl urea].
    ZAMPA GA
    G Clin Med; 1957 Jan; 38(1):42-57. PubMed ID: 13448420
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ambulant therapy of diabetics with hypoglycemic sulfonamide (BZ 55, nadisan, invenol)].
    HOFSTETTER JR; RAMEL C
    Helv Med Acta; 1956 Nov; 23(4-5):485-9. PubMed ID: 13398003
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of intravenous & oral N-sulfanilyl-N-butyl urea (BZ 55) on blood sugar in diabetics and persons with normal metabolism].
    PFEFFER KH; FUCHS KJ; MICHEL W; FOERDER HK
    Arztl Wochensch; 1957 Mar; 12(12):260-3. PubMed ID: 13410706
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences concerning the effects of N-sulfanilyl-N'-butyl urea in diabetes mellitus].
    TOLOMELLI E; BACCI L
    Rass Clin Ter; 1957; 56(1):1-16. PubMed ID: 13441924
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fatal encephalomyelitis after or because of N1-sulfanilyl-N2-n-butylcarbamide therapy of a diabetes case].
    BARTELHEIMER H
    Arztl Wochensch; 1957 Mar; 12(13):283-5. PubMed ID: 13410715
    [No Abstract]   [Full Text] [Related]  

  • 9. [First experiences with the new oral antidiabetic invenol].
    FIALA E; BALASSA M
    Orv Hetil; 1957 May; 98(21):554-5. PubMed ID: 13452526
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urinary excretion of acid mucopolysaccharides and mucoprotein in diabetics in basal conditions and after treatment with N-sulfanilyl-N'-butyl urea].
    GALLETTI F; PELLEGRINI R
    Arch Patol Clin Med; 1957; 33(3):153-64. PubMed ID: 13425840
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the total & renal clearance of N1-sulfanilyl-N2-n-butyl-carbamide (nadisan)].
    KLAUS D; STRIPECKE W
    Z Gesamte Inn Med; 1957 Apr; 12(7):289-94. PubMed ID: 13456727
    [No Abstract]   [Full Text] [Related]  

  • 12. [Examination of steroids in therapy with N'-sulfanilyl-N2-N-butylcarbamid (nadisan)].
    RAUSCH-STROOMANN JG; SAUER H
    Klin Wochenschr; 1956 Jul; 34(25-26):707-8. PubMed ID: 13347046
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of invenol on the carbohydrate and protein metabolism in diabetes mellitus.
    MUTING D
    Arztl Wochensch; 1957 Jan; 12(4):77-81. PubMed ID: 13402606
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activity of N-sulfanilyl-N' -butyl urea in normal and pancreatectomized dog].
    MIHICH E; PRINO G
    Farmaco Sci; 1956; 11(10):811-8. PubMed ID: 13414851
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with peroral administration of antidiabetic drug BZ-55 (invenol)].
    BRESGEN C
    Med Klin; 1956 Jul; 51(29):1224-7. PubMed ID: 13358484
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical contribution to the study of antidiabetic effect of NI-sulfamilyl-N2-n-Butyl carbamide].
    LAURIA D; NICOLETTI MN; ASCIONE A
    Riforma Med; 1957 Jun; 71(25):697-8. PubMed ID: 13454517
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of hypoglycemic coma in invenol therapy of diabetes mellitus].
    MELLANDER R
    Sven Lakartidn; 1957 Feb; 54(7):450-3. PubMed ID: 13422300
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of diabetes mellitus with nadisan in the clinic and in practice].
    BUSER M
    Helv Med Acta; 1956 Nov; 23(4-5):471-9. PubMed ID: 13398000
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemistry and pharmacology of a new peroral antidiabetic: ambolin].
    NOHARA FS
    Praxis; 1957 Apr; 46(16):359-61. PubMed ID: 13441532
    [No Abstract]   [Full Text] [Related]  

  • 20. [Case of very severe allergic reaction in peroral management of diabetes mellitus with a sulfonyl urea derivative, N1-sulfanilyl-N2-n-butylcarbamide].
    FELLER J; KUPPER HJ
    Medizinische; 1956 Nov; 1(46):1641-5. PubMed ID: 13386742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.